Cargando…

CircTmeff1 Promotes Muscle Atrophy by Interacting with TDP‐43 and Encoding A Novel TMEFF1‐339aa Protein

Skeletal muscle atrophy is a common clinical feature of many acute and chronic conditions. Circular RNAs (circRNAs) are covalently closed RNA transcripts that are involved in various physiological and pathological processes, but their role in muscle atrophy remains unknown. Global circRNA expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Rui, Yang, Tingting, Jin, Bing, Xu, Wanru, Yan, Yuwei, Wood, Nathanael, Lehmann, H. Immo, Wang, Siqi, Zhu, Xiaolan, Yuan, Weilin, Chen, Hongjian, Liu, Zhengyu, Li, Guoping, Bowen, T. Scott, Li, Jin, Xiao, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265041/ https://www.ncbi.nlm.nih.gov/pubmed/37088818 http://dx.doi.org/10.1002/advs.202206732

Ejemplares similares

The Role of circTmeff-1 in Morphine Addiction Memory of Mice
por: Yu, Hailei, et al.
Publicado: (2023)

Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines
por: Li, Kailiang, et al.
Publicado: (2019)

Tmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivo
por: Huang, Hao, et al.
Publicado: (2017)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2019)

TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease
por: Masood, Motasim, et al.
Publicado: (2020)

TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma
por: Lin, Kui, et al.
Publicado: (2011)

Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells
por: Nie, Xin, et al.
Publicado: (2021)

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer
por: Gaweł‐Bęben, Katarzyna, et al.
Publicado: (2017)

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer
por: Georgescu, Constantin, et al.
Publicado: (2019)

Butorphanol Inhibits the Malignant Biological Behaviors of Ovarian Cancer Cells via Down-Regulating the Expression of TMEFF1
por: Wang, Baosheng, et al.
Publicado: (2020)

TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway
por: Han, Hongchao, et al.
Publicado: (2019)

MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription
por: Tian, Jun, et al.
Publicado: (2022)

Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2
por: Overcash, Ryan F., et al.
Publicado: (2013)

Roles of miR-592-3p and Its Target Gene, TMEFF1, in the Nucleus Accumbens During Incubation of Morphine Craving
por: Xie, Bing, et al.
Publicado: (2022)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
por: Zhang, Lumi, et al.
Publicado: (2020)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
por: Deshimaru, Manami, et al.
Publicado: (2021)

MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways
por: Fan, Ji-min, et al.
Publicado: (2020)

A Novel Supplement Attenuates Oxidative Stress-Induced TDP-43-Related Pathogenesis in TDP-43-Expressed Cells
por: Yang, Eun Jin
Publicado: (2021)

Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
por: Gruijs da Silva, Lara A, et al.
Publicado: (2022)

Rodent Models of TDP-43 Proteinopathy: Investigating the Mechanisms of TDP-43-Mediated Neurodegeneration
por: Gendron, Tania F., et al.
Publicado: (2011)

Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
por: Ormeño, Fernando, et al.
Publicado: (2020)

TDP-43 crosses the divide
por: Leslie, Mitch
Publicado: (2015)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
por: Huang, Wendi, et al.
Publicado: (2020)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
por: Atkinson, Rachel, et al.
Publicado: (2021)

The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
por: Rengifo-Gonzalez, Juan Carlos, et al.
Publicado: (2021)

Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43
por: Keating, Sean S., et al.
Publicado: (2023)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
por: Pickles, Sarah, et al.
Publicado: (2022)

Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
por: Neumann, Manuela, et al.
Publicado: (2020)

The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43
por: Xu, Ya-Fei, et al.
Publicado: (2013)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration
por: Xie, Manling, et al.
Publicado: (2021)

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023)

Transposable Elements in TDP-43-Mediated Neurodegenerative Disorders
por: Li, Wanhe, et al.
Publicado: (2012)

Molecular Neuropathology of TDP-43 Proteinopathies
por: Neumann, Manuela
Publicado: (2009)

Mechanisms and models of TDP-43 proteinopathies
por: Petrucelli, Leonard
Publicado: (2012)

Drosophila Answers to TDP-43 Proteinopathies
por: Romano, Maurizio, et al.
Publicado: (2012)

Metals in ALS TDP-43 Pathology
por: Koski, Lassi, et al.
Publicado: (2021)

TDP-43 Pathology in Alzheimer’s Disease
por: Meneses, Axel, et al.
Publicado: (2021)

Divergent Phenotypes in Mutant TDP-43 Transgenic Mice Highlight Potential Confounds in TDP-43 Transgenic Modeling
por: D’Alton, Simon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_27co5l0e1jgnggtfqq1g66n84h